This article is part of the supplement: 2005 International Meeting of The Institute of Human Virology
Email this article to a friend
The MHC Class II Transactivator (CIITA): A "Physiologic" Drug Against HIV-1 Replication
-
* Corresponding author: Roberto S Accolla roberto.accolla@uninsubria.it
Retrovirology 2005, 2(Suppl 1):P2 doi:10.1186/1742-4690-2-S1-P2